HLA-DR Antigen Expression in Colorectal Carcinomas
Author Information
Author(s): K Matsushita, T Takenouchi, S Kobayashi, H Hayashi, K Okuyama, T Ochiai, A Mikata, K Isono
Primary Institution: Chiba University School of Medicine
Hypothesis
The study investigates the host's immune response against colorectal carcinoma through HLA-DR antigen expression.
Conclusion
HLA-DR antigen expression on carcinoma cells and adjacent normal epithelia is associated with less advanced tumor stages.
Supporting Evidence
- HLA-DR antigen was expressed in 55.1% of carcinoma cells and 75.5% of adjacent normal epithelia.
- Patients with HLA-DR staining were in less advanced Dukes' stages.
- Detection of IFN-y mRNA was associated with HLA-DR antigen expression.
Takeaway
The study found that certain markers in cancer cells can show how well the body's immune system is fighting the cancer.
Methodology
The study used immunohistochemistry to examine HLA-DR antigen expression and RT-PCR to detect mRNAs of cytokines in tissue samples.
Participant Demographics
49 Japanese patients (35 men and 14 women, age 35-84 years, average 61.3 years) with colorectal adenocarcinomas.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website